by Hormone replacement therapy (HRT) involves using female hormones, like estrogen and progesterone, to reduce the symptoms of menopause. The most common HRT approach is taking a pill daily that contains small amounts of estrogen and sometimes progesterone as well. This treatment has shown to effectively reduce hot flashes, night sweats, and other common menopause symptoms.
The global Hormone Replacement Therapy Market is estimated to be valued at US$ 14288.76 Mn in 2023 and is expected to exhibit a CAGR of 4.6%over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Growing prevalence of menopause
The growing prevalence of menopause worldwide is driving significant demand for hormone replacement therapy. According to the North American Menopause Society, an estimated 1.3 billion women worldwide will experience menopause by 2025. This demand is further driven by the rising average life expectancy of women globally. According to the World Health Organization (WHO), the average life expectancy of women has increased from 66 years in 1990 to 73.8 years in 2019. Moreover, increasing awareness about treatment options for menopause symptoms is also fueling the adoption of hormone replacement therapy across various countries.
SWOT Analysis
Strength: Presence of large established players with strong brand visibility. Wide range of products available for hormonal replacement.
Weakness: High costs associated with HRT treatment leading to low adoption in low-income countries. Side effects of long term HRT usage.
Opportunity: Increasing awareness about menopause and its treatment through social media and online platforms. Emerging markets in Asia Pacific and Latin America providing new growth avenues.
Threats: Risk of certain types of cancer with long term usage. Development of alternative treatment options.
Key Takeaways
Global Hormone Replacement Therapy Market is expected to witness high growth. The global Hormone Replacement Therapy Market is estimated to be valued at US$ 14288.76 Mn in 2023 and is expected to exhibit a CAGR of 4.6%over the forecast period 2023 to 2030.
The Asia Pacific region is expected to register the fastest growth during the forecast period. Countries like China, India, Japan, and South Korea are expected to drive the market in the region. Rising disposable incomes, growing awareness levels regarding menopause and availability of various generic HRT drugs at lower prices are some factors contributing to the regional market growth. North America currently dominates the global market owing to the availability of advanced healthcare systems and high treatment rates in countries like the US and Canada.
Key players related content comprises
Key players operating in the Hormone Replacement Therapy market are CMC Consumer Medical Care GMBH, Cotton Club, Groupe Lemoine Sanitars, Shiseido Co. Ltd., Sisma S.P.A, TZMO SA, L&R USA Inc., Unicharm Corporation, and PT Cottonindo Ariesta Tbk. These players are focusing on new product launches, mergers & acquisitions and geographical expansion to strengthen their market presence. For instance, in 2022, Shiseido acquired Drunk Elephant skincare company to expand its portfolio of premium beauty brands.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
